Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder
Clinical trial NCT02845323 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02845323
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-16
- Primary completion
- 2027-07-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.